Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahesh Goel

Showing results (201-210 of 213) with videos related to

Pageof 22
Sort By:
The Indian Journal of Medical Research|March 12, 2021
Indian Council of Medical Research consensus document on hepatocellular carcinomaBhawna Sirohi, Shailesh V Shrikhande, Vinay Gaikwad, et al.
Journal of Surgical Oncology|May 6, 2026
Surgical Management of Recurrent Retroperitoneal Sarcomas: Experience From a High-Volume Sarcoma Centre: Recurrent Retroperitoneal Sarcomas: Outcomes of Multiple RecurrencesAbdeali Saif Arif Kaderi, Tanvi M Shah, Shraddha Patkar, et al.
South Asian Journal of Cancer|December 22, 2025
High-Grade Gastrointestinal Neuroendocrine Carcinomas: Multidisciplinary Approach Can Improve Survival OutcomesNoorzia Syed, Anant Ramaswamy, Aditya Dhanawat, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 8, 2025
Development of a novel predictive nomogram to prevent 'futile surgery' in gallbladder cancers: A single center analysis of 1196 resected gallbladder cancersGurudutt P Varty, Shraddha Patkar, Mufaddal Kazi, et al.
The Journal of the Association of Physicians of India|May 22, 2022
Hepatocellular Carcinoma Evaluation and Management for Physicians: Joint Gastroenterology Research Society and Association of Physicians of India GuidelinesAkash Shukla, Aditya Kale, Amrit Gopan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2023
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)Vikas Ostwal, Sarika Mandavkar, Prabhat Bhargava, et al.
JAMA Oncology|July 3, 2024
Adjuvant Gemcitabine Plus Cisplatin and Chemoradiation in Patients With Gallbladder Cancer: A Randomized Clinical TrialVikas Ostwal, Shraddha Patkar, Reena Engineer, et al.
Indian Journal of Cancer|March 1, 2024
Tata Memorial Centre Evidence Based Management of Colorectal cancerAvanish Saklani, Mufaddal Kazi, Ashwin Desouza, et al.
Annals of Surgery|June 11, 2020
Outcomes of Elective Major Cancer Surgery During COVID 19 at Tata Memorial Centre: Implications for Cancer Care PolicyShailesh V Shrikhande, Prathmesh S Pai, Manish S Bhandare, et al.
BMC Cancer|October 29, 2025
PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)Ameya D Puranik, Indraja D Dev, Sushil Yadav, et al.
Pageof 22

Showing results (201-210 of 213) with videos related to

Sort By:
Pageof 22
The Indian Journal of Medical Research|March 12, 2021
Indian Council of Medical Research consensus document on hepatocellular carcinomaBhawna Sirohi, Shailesh V Shrikhande, Vinay Gaikwad, et al.
Journal of Surgical Oncology|May 6, 2026
Surgical Management of Recurrent Retroperitoneal Sarcomas: Experience From a High-Volume Sarcoma Centre: Recurrent Retroperitoneal Sarcomas: Outcomes of Multiple RecurrencesAbdeali Saif Arif Kaderi, Tanvi M Shah, Shraddha Patkar, et al.
South Asian Journal of Cancer|December 22, 2025
High-Grade Gastrointestinal Neuroendocrine Carcinomas: Multidisciplinary Approach Can Improve Survival OutcomesNoorzia Syed, Anant Ramaswamy, Aditya Dhanawat, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 8, 2025
Development of a novel predictive nomogram to prevent 'futile surgery' in gallbladder cancers: A single center analysis of 1196 resected gallbladder cancersGurudutt P Varty, Shraddha Patkar, Mufaddal Kazi, et al.
The Journal of the Association of Physicians of India|May 22, 2022
Hepatocellular Carcinoma Evaluation and Management for Physicians: Joint Gastroenterology Research Society and Association of Physicians of India GuidelinesAkash Shukla, Aditya Kale, Amrit Gopan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2023
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)Vikas Ostwal, Sarika Mandavkar, Prabhat Bhargava, et al.
JAMA Oncology|July 3, 2024
Adjuvant Gemcitabine Plus Cisplatin and Chemoradiation in Patients With Gallbladder Cancer: A Randomized Clinical TrialVikas Ostwal, Shraddha Patkar, Reena Engineer, et al.
Indian Journal of Cancer|March 1, 2024
Tata Memorial Centre Evidence Based Management of Colorectal cancerAvanish Saklani, Mufaddal Kazi, Ashwin Desouza, et al.
Annals of Surgery|June 11, 2020
Outcomes of Elective Major Cancer Surgery During COVID 19 at Tata Memorial Centre: Implications for Cancer Care PolicyShailesh V Shrikhande, Prathmesh S Pai, Manish S Bhandare, et al.
BMC Cancer|October 29, 2025
PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)Ameya D Puranik, Indraja D Dev, Sushil Yadav, et al.
Pageof 22